Quantitative hepatitis B surface antigen assays show troubling inter-method variability

This Clinical Chemistry piece highlights significant variability between three quantitative hepatitis B surface antigen assays, raising the question of which result clinicians should trust. The lack of standardisation across platforms has direct implications for patient management decisions that rely on HBsAg quantification, including treatment initiation and monitoring.